Introduction: Benign prostatic hyperplasia (BPH) may ultimately result in acute urinary retention (AUR). This study was performed to assess the impact of transurethral resection of the prostate (TURP) on urodynamic parameters in patients with BPH using pre- and postoperative pressure-flow studies (PFS) and compare those between patients with and without preoperative AUR. Patients and Methods: 78 patients underwent TURP because of symptoms due to BPH and were evaluated preoperatively and at follow-up after a mean ± SD of 27 ± 11.5 months by the International Prostate Symptom Score and PFS. Results: 32% of patients were admitted with AUR. The clinical and principal urodynamic parameters exhibited statistically significant improvement reaching normal values after TURP in most patients. Comparing patients with and without AUR, the bladder compliance significantly increased (p = 0.0013) from the preoperative period to follow-up only in patients with preoperative AUR. The minimal opening pressure decreased significantly more (p = 0.0077) from the preoperative period to follow-up in the non-AUR group. Patients older than 80 years and younger patients showed comparable results. Conclusions: TURP leads to a sustained and age-independent improvement of clinically relevant PFS parameters in patients with BPH. Patients with preoperative AUR had comparable symptomatic, but an impaired urodynamic outcome compared to patients without AUR.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.